🇺🇸 FDA
Patent

US 10661095

Photodynamic therapy for use in treating cancer

granted A61KA61K33/34A61K9/0009

Quick answer

US patent 10661095 (Photodynamic therapy for use in treating cancer) held by The Board of Regents of the University of Texas System expires Mon May 21 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue May 26 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 21 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
7
CPC classes
A61K, A61K33/34, A61K9/0009, A61K9/5115